Trifecta Capital Advisors, LLC
Position in CAI — Caris Life Sciences, Inc.
CIK 1962615
NORTHBROOK, IL
Position in CAI
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$37,422
New position
Shares Held
2,100
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#191
of 246 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trifecta Capital Advisors, LLC holds $8,474,760 across 8 Biotechnology names. CAI ranks #3 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,745 | $8,317,743 | |
| 2 | DRTS |
Alpha Tau Medical Ltd.
|
8,750 | $110,075 | |
| 3 | CAI |
Caris Life Sciences, Inc.
This page
|
2,100 | $37,422 | |
| 4 | ARMP |
Armata Pharmaceuticals, Inc.
|
714 | $4,626 | |
| 5 | BYSI |
BeyondSpring Inc.
|
1,500 | $2,625 | |
| 6 | ARGX |
Argenx SE
|
2 | $1,855 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4 | $227 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
1 | $187 |
All Filings in CAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,422 | 2,100 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||